Meadow Creek Investment Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-9,688
Closed -$56K – 1378
2019
Q1
$56K Hold
9,688
– – ﹤0.01% 1262
2018
Q4
$130K Buy
9,688
+1,568
+19% +$26.4K ﹤0.01% 1093
2018
Q3
$158K Buy
8,120
+2,772
+52% +$59K ﹤0.01% 1145
2018
Q2
$137K Buy
5,348
+56
+1% +$1.31K ﹤0.01% 1114
2018
Q1
$107K Buy
+5,292
New +$123K ﹤0.01% 1189
2017
Q1
– Sell
-1,400
Closed -$18K – 1320
2016
Q4
$18K Buy
+1,400
New +$26.1K ﹤0.01% 1250

Other funds holding DPLO

Meadow Creek Investment Management's DPLO Position: Q2 2019 in Review

Meadow Creek Investment Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2019, closing a stake of 9,688 shares — an estimated $56K sold.

Meadow Creek Investment Management first reported a position in DPLO in Q4 2016 and held it in 6 quarters. The position peaked at $158K in Q3 2018. 131 funds tracked by Wall St. Rank hold DPLO as of Q2 2019.

  • Meadow Creek Investment Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2019 after selling out during the quarter.
  • Meadow Creek Investment Management sold 9,688 DIPLOMAT PHARMACY, INC. shares in Q2 2019, an estimated $56K.
  • Meadow Creek Investment Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2016 and held it in 6 quarters.
  • Meadow Creek Investment Management's DIPLOMAT PHARMACY, INC. position peaked at $158K in Q3 2018.
  • 131 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2019.

Based on Meadow Creek Investment Management's 13F filing for Q2 2019, filed 13 Aug 2019.